back to top
HomeSHARE MARKETQIP From Pharma Company Share; Company Has Fixed The Floor Price For...

QIP From Pharma Company Share; Company Has Fixed The Floor Price For QIP At Rs 544.02 Per Share

Hot Stocks Alert Join

Wockhardt Ltd (NSE – BE: WOCKPHARMA) QIP: Pharma company Wockhardt Ltd has come up with Qualified Institutional Placement (QIP). It opened on 20 March. The capital raising committee of the company has fixed the floor price for QIP at Rs 544.02 per share. 

Sources told that the total size of the QIP is estimated to be Rs 570 crore, which includes fresh shares worth Rs 350 crore and greenshoe options worth Rs 220 crore.

The capital raising committee will meet again on 26 March to finalize details of the QIP, including the price at which it will be issued and the other issues. Wockhardt Ltd is allowed to offer a discount of up to five percent on the floor price when determining the price of the stock.

What Impact On Wockhardt’s Share Price?

Wockhardt Ltd shares are rising on March 21. The stock opened at Rs 570 on BSE in the morning with an increase of about 5 percent from the previous closing price. 

At the end of trading, the stock closed at Rs 547.90 with a gain of 0.32 percent. The stock’s 52-week high is Rs 630 and the low is Rs 145.35. 

The market cap of the company on BSE is around Rs 8000 crore. The price range for this share is Rs. 571.35, and Rs. 516.95. The circuit limit is 5 percent.

Wockhardt Ltd shares have gained 218 percent in the last 5 years. According to BSE, Wockhardt Ltd’s revenue in the December 2023 quarter was Rs 288 crore. 

The research and development facilities and manufacturing facilities of the company are located in India, USA UK Ireland, and UAE. Wockhardt Ltd is present in over 30 countries on 6 continents.

About Wockhardt Ltd Company 

Wockhardt Limited is a biotechnology as well as pharmaceutical firm.

The company engages in manufacturing and marketing. Pharmaceutical formulations, active pharmaceutical ingredients, and vaccines are all included.

The company offers a variety of dosage forms: sterile injections, Lyophilized products, etc.

The Company provides products for dermatology, cosmeceuticals, and oncology. The clinic also provides medical nutrition, osteoarthritis, cough therapy, diabetology, and nephrology.

In India, the Company offers a variety of products.These are Citawok Forte, Citawok Plus, CONSEGNA U200 Cart, CONSEGNA U200 B Cart, Emrok O Cart, Erliso Cart, FOSCHEK – S Cart, Gabawok NT Cart, Glimaday Cart, Glimaday NT Cart, Glimaday NT Cart, Glimaday NT, etc.

Company’s manufacturing centers and research centers: India, the United States of America, and the United Kingdom.

Fundamental Analysis of Wockhardt Ltd

Market Cap₹ 7,941 Cr.
Current Price₹ 547.90
52-wk High₹ 630 
52-wk Low₹ 145
Stock P/E
Book Value₹ 217
Dividend0.00 %
ROCE-0.46 %
ROE-8.31 %
Face Value₹ 5.00
P/B Value2.53
OPM4.61 %
EPS₹ -34.8
Debt₹ 2,274 Cr.
Debt to Equity0.73

Wockhardt Ltd Share Price Target 2024 To 2030

Year1st Target2nd Target
Hot Stocks Alert Join

Wockhardt Ltd Shareholding Pattern

Promoters Holding
Dec 202260.36%
Mar 202359.31%
June 202358.40%
Sept 202355.14%
Dec 202354.93%
FII Holding
Dec 20222.87%
Mar 20232.78%
June 20232.60%
Sept 20233.03%
Dec 20234.18%
DII Holding
Dec 20220.22%
Mar 20230.22%
June 20230.18%
Sept 20230.21%
Dec 20230.30%
Hot Stocks Alert Join
Public Holding
Dec 202236.55%
Mar 202337.70%
June 202338.83%
Sept 202341.62%
Dec 202340.59%

Wockhardt Ltd Share: Last 5 Years’ Financial Condition

To better understand how the market is performing, let’s look at the outlook of this share in the previous years. 

However, investors should be aware of the risks and the market conditions before making any investment decision.

Last 5 Years’ Sales:

2019₹ 3,566 Cr
2020₹ 2,844 Cr
2021₹ 2,708 Cr
2022₹ 3,230 Cr
2023₹ 2,776 Cr

Last 5 Years’ Net Profit:

2019₹ -217 Cr
2020₹ -43 Cr
2021₹ 688 Cr
2022₹ -279 Cr
2023₹ -532 Cr
Hot Stocks Alert Join

Last 5 Years’ Debt-To-Equity Ratio:


Last 10 Years’ Profit Growth:

10 Years:
5 Years:3%
3 Years:
Current Year:-50%

Last 10 years’ Return on Equity (ROE):

10 Years:3%
5 Years:1%
3 Years:4%
Last Year:-8%

Sales Growth Over 10 Years:

10 Years:-7%
5 Years:-8%
3 Years:-2%
Current Year:6%


This article is a complete guide about Wockhardt Ltd Share. This information and forecasts are based on our research, company fundamentals, history, experiences, and technical analyses. 

Also, We have discussed the share’s prospects and growth potential in detail.

This information will help you in your further investment. 

If you are new to our website and want to get all the latest updates related to the stock market, join us on Telegram Group.

If you have any further queries, please comment below. We will be happy to answer all your questions. 

If you like this information, share the article with as many people as possible.



Please enter your comment!
Please enter your name here